{"id":17286,"date":"2022-04-24T22:09:16","date_gmt":"2022-04-24T09:09:16","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=17286"},"modified":"2022-04-25T18:13:32","modified_gmt":"2022-04-25T05:13:32","slug":"cll-advocates-newsletter","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=17286","title":{"rendered":"Our Advocacy Priorities for 2022 &#8211; CLL Advocates April Newsletter"},"content":{"rendered":"<div data-canvas-width=\"151.96133333333336\">\n<p><strong>Our Advocacy Priorities for 2022<\/strong><\/p>\n<p>CLL Advocates April 2022 Newsletter<\/p>\n<p>&nbsp;<\/p>\n<p>April 2022<\/p>\n<p>&nbsp;<\/p>\n<p>Dear Friends,<\/p>\n<p>&nbsp;<\/p>\n<p>The year is well under way, and we\u2019re firmly focused on where we need to direct our energies and resources this year. \u00a0We\u2019ve agreed on the following as the key priorities for improving outcomes for CLL patients:<\/p>\n<ol>\n<li>Access to new treatments, notably BTK inhibitors, for relapsed CLL<\/li>\n<li>Reform of first line therapy<\/li>\n<li>Equitable access to clinical trials of unfunded CLL treatments<\/li>\n<li>The availability in NZ of testing to identify the IgVH mutation<\/li>\n<li>Prevention and management of infections in CLL patients, and<\/li>\n<li>Prevention or early detection of secondary malignancies in CLL patients.<\/li>\n<\/ol>\n<p>As well as these CLL specific goals, we want to pursue the broader goal of achieving an effective, more meaningful patient voice in medicines funding decisions in NZ. (More on this in a future newsletter).<\/p>\n<p>This is an ambitious agenda! \u00a0And we are a very small group, but we believe with your engagement and support, and the help of our donors, we will be able to make some headway.<\/p>\n<p>We have a workplan for the year, and early on in the agenda is a series of patient focus groups to identify the specific issues of most importance to you, and how we can best help you with these. We\u2019re also keen to hear any experiences you\u2019ve had that can help us focus our advocacy efforts effectively.<\/p>\n<p>These would initially be small groups of, say, four to six, and would be on Zoom, depending on the Covid environment and geographic constraints. They would be facilitated, friendly, caf\u00e9 style discussions. Caregivers and family members would also be welcome.<\/p>\n<p>We will get in touch with you soon to set up these discussions, but in the meantime please can you get in touch with us at <a href=\"mailto:trustees@clladvocates.nz\">trustees@clladvocates.nz<\/a> to let us know if you\u2019re interested.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Help required!<\/strong><\/p>\n<p>We\u2019re also still greatly in need of help to keep CLLANZ going, so if there\u2019s any task you\u2019re willing to take on, no matter how small, please let us know!<\/p>\n<p>&nbsp;<\/p>\n<p>Best wishes<\/p>\n<p>CLL Advocates NZ Trustees<\/p>\n<p><a href=\"mailto:trustees@clladvocates.nz\">trustees@clladvocates.nz<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Our Advocacy Priorities for 2022 CLL Advocates April 2022 Newsletter &nbsp; April 2022 &nbsp; Dear Friends, &nbsp; The year is [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":17288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12,17,21],"tags":[37],"class_list":["post-17286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","category-featured","category-newsletter","tag-cll-advocates-newsletter"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2022\/04\/newsletter-3723465_1280.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/17286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17286"}],"version-history":[{"count":9,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/17286\/revisions"}],"predecessor-version":[{"id":17304,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/17286\/revisions\/17304"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/17288"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}